Tirzepatide: A Promising Drug for Type 2 Diabetes and Beyond

Tirzepatide is a promising drug with dual-acting glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide 1 (GLP-1) receptor activation that has revolutionized the treatment of type 2 diabetes mellitus (T2DM) as an adjunct to diet and exercise. In phase 3 clinical trials (SURPASS...

Descripción completa

Detalles Bibliográficos
Autores principales: Dutta, Palak, Kumar, Yashaank, Babu, Alexis T, Giri Ravindran, Suganya, Salam, Ajal, Rai, Bhumish, Baskar, Aakash, Dhawan, Ananya, Jomy, Manjima
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Endocrinology/Diabetes/Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10231274/
https://www.ncbi.nlm.nih.gov/pubmed/37265914
http://dx.doi.org/10.7759/cureus.38379

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10231274/
https://www.ncbi.nlm.nih.gov/pubmed/37265914
http://dx.doi.org/10.7759/cureus.38379

Ejemplares similares